
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 99.970 | 99.970 | 0.000 |
Other | 0.060 | 0.060 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.198 | 22.116 |
Price to Book | 1.602 | 4.390 |
Price to Sales | 1.366 | 2.804 |
Price to Cash Flow | 6.492 | 14.005 |
Dividend Yield | 2.802 | 1.489 |
5 Years Earnings Growth | 10.332 | 10.405 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 22.040 | 17.545 |
Technology | 20.020 | 26.744 |
Healthcare | 16.330 | 12.725 |
Industrials | 10.230 | 8.500 |
Consumer Defensive | 9.580 | 6.757 |
Consumer Cyclical | 7.200 | 10.832 |
Communication Services | 5.280 | 9.361 |
Basic Materials | 4.680 | 2.740 |
Energy | 4.650 | 3.742 |
Number of long holdings: 34
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Maxar Technologies Inc | - | 5.98 | - | - | |
Apple Inc | - | 5.31 | - | - | |
Citigroup Inc | - | 5.26 | - | - | |
Bank of America Corp | - | 5.19 | - | - | |
JPMorgan Chase & Co | - | 5.05 | - | - | |
Wells Fargo & Co | - | 4.98 | - | - | |
Oracle Corp | - | 4.93 | - | - | |
Johnson & Johnson | - | 4.24 | - | - | |
Cisco Systems Inc | - | 3.79 | - | - | |
CVS Health Corp | - | 3.78 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mackenzie Cundill Value Fund A | 877.58M | 8.40 | 15.30 | 4.01 | ||
Mackenzie Cundill Canadian Sec A | 420.55M | 8.68 | 14.77 | 5.36 | ||
Mackenzie Cundill Canadian Bal A | 379.65M | 5.74 | 10.23 | 3.82 | ||
Mackenzie Canadian Resource A | 282.06M | 14.03 | 11.68 | 8.74 | ||
Mackenzie US Dividend Fund Series A | 92.44M | 0.19 | 10.77 | 8.03 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review